Would you consider using a JAK inhibitor for CTCL?

Community PollStarted

Would you use a JAK inhibitor for CTCL?

42 physicians have voted

Join Mednetto vote and see how they answered.

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

In an older patient with pembrolizumab-associated chronic eczematous dermatitis—worsened by dupilumab and with biopsies showing spongiotic dermatitis with atypical lymphocytes, would a trial of a JAK inhibitor be appropriate while monitoring for possible early CTCL?

What is your approach to prescribing JAK inhibitors in patients with alopecia areata who have a prior history of cutaneous malignancy, such as DFSP?

Do you generally treat family members of patients with scabies?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.